Novartis Posted September 6, 2026

New Products Lead

Shanghai (Shanghai), China FULL_TIME
Notify me about similar jobs
This position may no longer be available.

We couldn't confirm this posting on Novartis's site in our latest checks -- see current similar openings below.

View the original listing (may no longer be live).

About this opportunity

Act as the China commercial representative for new oncology products, leading pipeline launch planning, integrating commercial insights into early clinical development, shaping local/regional/global brand strategies, and driving country launch excellence and long-term portfolio growth within the relevant therapeutic area.

Major Accountabilities:Lead the launch of ONCO pipelines by partnering with various internal departments and external stakeholders, including but not limited to Development Unit, Therapeutic Area Commercial, and Business Development Ensure commercial inputs during the early stages of clinical trials to support business decision-making, develop a clear brand strategy, and drive solid launch preparation to achieve launch excellence. Actively contribute to the development of the Global and Unit Brand Strategy and strategic planning processes. Ensure the long-term presence of the product portfolio in the pharmaceutical market in alignment with strategic goals. Key Requirements:7-10 years working experience in healthcare industry, with previous work experience in the field of healthcare system readiness for oncology/solid tumor preferred. Strong analytical, problem-solving, and systems-thinking capabilities, with the ability to synthesize complex scientific, clinical development, policy, regulatory, healthcare system, and commercial information into actionable business insights and internal strategies for new product planning and innovation. Excellent communication and stakeholder management skills and comfortable working in a fast-paced, cross-functional environment. Successfully managed complex projects with high visibility, ability to lead without authority. Quick learner, Agile working attitude and a team collaborator. Master’s degree required.  Advanced degree in life sciences/biology, medicine, business, or related field preferred strongly preferred. Prior experience at MBB or a top-tier strategy consulting firm is preferred. Fluent Mandarin/English required

Job details

Seniority
Not listed
Function
BD&L & Strategic Planning
Therapeutic area
Not listed
Location
Shanghai (Shanghai), China
Employment type
FULL_TIME

How this role compares

Computed from every other active BD&L & Strategic Planning role in our database, not just this employer's listings.

We currently track 396 comparable BD&L & Strategic Planning roles across 79 biopharma companies.

396Comparable roles tracked
362Currently active
79Companies hiring similar roles
41Countries represented

Salary context

127 of 396 peers report a salary range (USD, annualized)

Peers share this role's job function. This posting doesn't list a seniority level, so peers aren't narrowed by seniority either -- the range below may span more levels than usual.

This roleSubject Not listed on this posting
Lowest disclosed · Manager, Portfolio Management · Sandoz $0/hr – $0/hr (≈ $0–$0/yr)
Peer group range $0 – $380,750 (median $209,400)

Where these roles are based

Top locations among the 396 comparable roles

United States188
China55
United Kingdom17
India16
Germany15
Switzerland12

+ 35 more countries

Seniority mix

286 of 396 peers have a known seniority level

Director92
Manager71
Associate Director42
Senior Director30
Intern/Fellow/Postdoc16
Senior15
Principal8
Executive/VP7
Associate5

Therapeutic area mix

66 of 396 peers have a known therapeutic area; the rest are genuinely unlabeled, not hidden

Oncology20
Neuroscience12
Immunology12
Dermatology & Aesthetics11
Vaccines & Infectious Disease3
Cardiovascular / CVRM2
Respiratory2
Gastroenterology2
Rare Disease1
Ophthalmology1

Currently open similar roles

This posting is closed, but here are live openings closest to it -- ranked by similarity, not by how well you'd qualify for them.

40%similar
Lilly Shanghai, Shanghai, China Senior Director
Same function Same country
40%similar
Pfizer Investment Co., Ltd. China Shanghai, China
Same function Same country
40%similar
Shenzhen Sanofi Biological Products Co., Ltd. Beijing, China Senior Director
Same function Same country
40%similar
Novartis Shanghai (Shanghai), China Associate Director
Same function Same country
40%similar
Novartis Shanghai (Shanghai), China Director
Same function Same country
40%similar
Novartis Shanghai (Shanghai), China Director
Same function Same country

Notify me about similar jobs

Get an email when we spot other openings like this one – same job function, comparable seniority, roles you'd actually want to see.

Or follow a whole field: get every new BD&L & Strategic Planning job in China, and choose locations and companies.

How we calculate "similar"

No black box, no LLM guesswork: a deterministic score built from four normalized attributes. Here's this role's own peer group at different match levels, so you can see the mechanism, not just the result.

Every comparison starts from the same 100-point budget: 25 for working in the same function, 40 for the same therapeutic area, 20 for the same or adjacent seniority, 15 for the same country. A dimension we can't confirm on both sides contributes nothing, never a guess, never a free pass.

40%
Senior Director--External Innovation
Lilly · Shanghai, Shanghai, China · Senior Director
Function Therapeutic area Seniority Country
40%
Associate Director Search & Evaluation
Novartis · Shanghai (Shanghai), China · Associate Director
Function Therapeutic area Seniority Country
40%
Director, Alliance Management
Novartis · Shanghai (Shanghai), China · Director
Function Therapeutic area Seniority Country
40%
Investment Director, Venture Fund (Shanghai, China)
Boehringer Ingelheim · Shanghai, China · Director
Function Therapeutic area Seniority Country
Unmatched or unknown dimensions score exactly the same: 0 points, never a partial guess. A role we know almost nothing about beyond its function bottoms out at 25%; it never inflates to 100% just because there's little to compare against. Seniority uses a defined ladder (Associate → Manager → Associate Director → Senior → Principal → Director → Senior Director → Executive/VP) so "Director" and "Senior Director" count as adjacent, but "Director" and "Executive/VP" do not.